Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleCLINICAL INVESTIGATIONS

The Value of the Dopamine D2/3 Receptor Ligand 18F-Desmethoxyfallypride for the Differentiation of Idiopathic and Nonidiopathic Parkinsonian Syndromes

Christian la Fougère, Gabriele Pöpperl, Johannes Levin, Björn Wängler, Guido Böning, Christopher Uebleis, Paul Cumming, Peter Bartenstein, Kai Bötzel and Klaus Tatsch
Journal of Nuclear Medicine April 2010, 51 (4) 581-587; DOI: https://doi.org/10.2967/jnumed.109.071811
Christian la Fougère
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriele Pöpperl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johannes Levin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Björn Wängler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guido Böning
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Uebleis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Cumming
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Bartenstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kai Bötzel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Klaus Tatsch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1. 

    Striatal dopamine D2/3 receptor binding of 18F-DMFP in 1 patient with non-IPS (A) and 1 patient with IPS (B). Decreased D2/3 receptor binding, which was predominant in dorsal part of striatum, is shown in non-IPS (A), whereas increased D2/3 receptor binding mainly in posterior putamen could be discerned even visually (B) and was interpreted as relative sparing of D2/3 receptor.

  • FIGURE 2. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2. 

    (A) ROC for SB in caudate nucleus, anterior and posterior putamen, putamen, and striatum. (B) ROC for individual ratios: P to NC, PP to NC, and PP to PA.

Tables

  • Figures
    • View popup
    TABLE 1

    SB in All Striatal Regions, Ratios, and Absolute Lateralization Indices in Patients with IPS and Non-IPS

    IPSNon-IPSSensitivity (%)Specificity (%)Accuracy (%)
    Binding and regionMean ± SDRangeMean ± SDRangePROC (AUC ± SE)NPV (%)PPV (%)
    Dopamine D2/3–specific binding
     Striatum2.16 ± 0.321.52–2.961.55 ± 0.280.86–2.00<0.0010.936 ± 0.02786.590.988.988.988.9
     Caudate nucleus1.91 ± 0.321.23–2.661.48 ± 0.250.84–1.98<0.0010.859 ± 0.04173.086.479.281.880.2
     Putamen2.23 ± 0.331.60–3.041.57 ± 0.310.79–2.08<0.0010.944 ± 0.02486.593.289.191.490.1
     Anterior putamen2.12 ± 0.311.54–2.971.62 ± 0.281.00–2.12<0.0010.894 ± 0.03683.886.486.483.885.2
     Posterior putamen2.42 ± 0.391.67–3.311.49 ± 0.420.46–2.13<0.0010.970 ± 0.01686.595.589.494.191.4
    P-to-NC ratio1.18 ± 0.101.07 ± 0.20<0.010.690 ± 0.05881.147.775.056.663.0
    PP-to-NC ratio1.27 ± 0.131.02 ± 0.28<0.0010.830 ± 0.04581.175.082.573.277.8
    PP-to-PA ratio1.14 ± 0.090.91 ± 0.18<0.0010.907 ± 0.03283.881.885.779.582.7
    Combination SBPP and PP-to-PA ratio————97.384.197.483.790.1
    ALI
     Striatum0.05 ± 0.040.10 ± 0.10<0.010.372 ± 0.06245.943.248.740.544.4
     Caudate nucleus0.08 ± 0.070.10 ± 0.06>0.050.357 ± 0.06362.220.539.139.739.5
     Anterior putamen0.05 ± 0.030.10 ± 0.11<0.010.329 ± 0.05975.711.435.741.840.7
     Posterior putamen0.08 ± 0.060.17 ± 0.18<0.010.340 ± 0.06086.511.450.045.145.7
    Discriminant analysis (SBPP, PP-to-PA ratio, and PP-to-NC ratio)————91.995.593.394.493.8
    • Level of significance from Student t test (P); AUC with respective SE from ROC analysis; and sensitivity, specificity, NPV, PPV, and accuracy for optimal specific binding threshold are presented.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 51 (4)
Journal of Nuclear Medicine
Vol. 51, Issue 4
April 2010
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Value of the Dopamine D2/3 Receptor Ligand 18F-Desmethoxyfallypride for the Differentiation of Idiopathic and Nonidiopathic Parkinsonian Syndromes
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The Value of the Dopamine D2/3 Receptor Ligand 18F-Desmethoxyfallypride for the Differentiation of Idiopathic and Nonidiopathic Parkinsonian Syndromes
Christian la Fougère, Gabriele Pöpperl, Johannes Levin, Björn Wängler, Guido Böning, Christopher Uebleis, Paul Cumming, Peter Bartenstein, Kai Bötzel, Klaus Tatsch
Journal of Nuclear Medicine Apr 2010, 51 (4) 581-587; DOI: 10.2967/jnumed.109.071811

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Value of the Dopamine D2/3 Receptor Ligand 18F-Desmethoxyfallypride for the Differentiation of Idiopathic and Nonidiopathic Parkinsonian Syndromes
Christian la Fougère, Gabriele Pöpperl, Johannes Levin, Björn Wängler, Guido Böning, Christopher Uebleis, Paul Cumming, Peter Bartenstein, Kai Bötzel, Klaus Tatsch
Journal of Nuclear Medicine Apr 2010, 51 (4) 581-587; DOI: 10.2967/jnumed.109.071811
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Nigrostriatal Dopamine Terminal Imaging with Dopamine Transporter SPECT: An Update
  • Assessment of Striatal Dopamine D2/D3 Receptor Availability with PET and 18F-Desmethoxyfallypride: Comparison of Imaging Protocols Suited for Clinical Routine
  • Postural imbalance and falls in PSP correlate with functional pathology of the thalamus
  • Diagnostic Accuracy of Combined FP-CIT, IBZM, and MIBG Scintigraphy in the Differential Diagnosis of Degenerative Parkinsonism: A Multidimensional Statistical Approach
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire